Literature DB >> 14532223

Use of hepatitis B virus DNA quantitation to predict hepatitis B e antigen reversion in cases of chronic hepatitis B.

Henry Lik-Yuen Chan1, May Ling Wong, Alex Yui Hui, Lawrence Cheung-Tsui Hung, Francis Ka-Leung Chan, Joseph Jao-Yiu Sung.   

Abstract

Seventy-three chronic hepatitis B patients who had either hepatitis B e antigen (HBeAg) seroconversion (group I) or HBeAg-negative disease (group II) were studied. HBV DNA levels at HBeAg seroconversion (group I) and at initial visits (group II) were significantly lower among patients who were persistently negative for HBeAg than among those who underwent HBeAg reversion.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14532223      PMCID： PMC294957          DOI： 10.1128/JCM.41.10.4793-4795.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  18 in total

Review 1.  Management of hepatitis B: 2000--summary of a workshop.

Authors:  A S Lok; E J Heathcote; J H Hoofnagle
Journal:  Gastroenterology       Date:  2001-06       Impact factor: 22.682

2.  Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong.

Authors:  H L Chan; N W Leung; M Hussain; M L Wong; A S Lok
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

3.  Risk factors for active liver disease in HBeAg-negative chronic hepatitis B virus-infected patients.

Authors:  H L Chan; Y Hui; N W Leung; J Y Ching; F K Chan; J J Sung
Journal:  Am J Gastroenterol       Date:  2000-12       Impact factor: 10.864

4.  The long-term course of chronic hepatitis B.

Authors:  V Di Marco; O Lo Iacono; C Cammà; A Vaccaro; M Giunta; G Martorana; P Fuschi; P L Almasio; A Craxì
Journal:  Hepatology       Date:  1999-07       Impact factor: 17.425

5.  Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus.

Authors:  B J McMahon; P Holck; L Bulkow; M Snowball
Journal:  Ann Intern Med       Date:  2001-11-06       Impact factor: 25.391

6.  Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection.

Authors:  Henry Lik-Yuen Chan; Steven Woon-Choi Tsang; Chook-Tiew Liew; Chi-Hang Tse; May-Ling Wong; Jessica Yuet-ling Ching; Nancy Wai-Yee Leung; John Siu-Lun Tam; Joseph Jao-Yiu Sung
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

7.  Relationship of clinical and virological factors with hepatitis activity in hepatitis B e antigen-negative chronic hepatitis B virus-infected patients.

Authors:  Joseph J-Y Sung; H L-Y Chan; M L Wong; C-H Tse; S C-H Yuen; J S-L Tam; N W-Y Leung
Journal:  J Viral Hepat       Date:  2002-05       Impact factor: 3.728

8.  High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system.

Authors:  K R Loeb; K R Jerome; J Goddard; M Huang; A Cent; L Corey
Journal:  Hepatology       Date:  2000-09       Impact factor: 17.425

9.  Serum hepatitis B virus DNA levels and liver histology in inactive HBsAg carriers.

Authors:  Michelle Martinot-Peignoux; Nathalie Boyer; Magalie Colombat; Rahouda Akremi; Bach-Nga Pham; Stephan Ollivier; Corinne Castelnau; Donimique Valla; Claude Degott; Patrick Marcellin
Journal:  J Hepatol       Date:  2002-04       Impact factor: 25.083

10.  Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.

Authors:  Yao-Shih Hsu; Rong-Nan Chien; Chau-Ting Yeh; I-Shyan Sheen; Hung-Yi Chiou; Chia-Ming Chu; Yun-Fan Liaw
Journal:  Hepatology       Date:  2002-06       Impact factor: 17.425
View more
  4 in total

1.  Hepatitis B e Antigen Negative Chronic Hepatitis in Indian Patients : A Reality.

Authors:  K K Lahiri; A K Sahni; R M Gupta; S D Duhan; K Kapila; J Jena
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.

Authors:  Sang Hoon Ahn; Henry L Y Chan; Pei-Jer Chen; Jun Cheng; Mahesh K Goenka; Jinlin Hou; Seng Gee Lim; Masao Omata; Teerha Piratvisuth; Qing Xie; Hyung Joon Yim; Man-Fung Yuen
Journal:  Hepatol Int       Date:  2010-02-20       Impact factor: 6.047

3.  Evaluation of impact of serial hepatitis B virus DNA levels on development of hepatocellular carcinoma.

Authors:  Henry Lik-Yuen Chan; Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Angel Mei-Ling Chim; Larry Hin Lai; Joseph Jao-Yiu Sung
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

4.  Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.

Authors:  H L-Y Chan; A Y Hui; M L Wong; A M-L Tse; L C-T Hung; V W-S Wong; J J-Y Sung
Journal:  Gut       Date:  2004-10       Impact factor: 23.059
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.